KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2025)

Amneal Pharmaceuticals has reported Cash from Operations over the past 9 years, most recently at 130315000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 130315000.0 for Q4 2025, up 10.36% from a year ago — trailing twelve months through Dec 2025 was 339992000.0 (up 15.21% YoY), and the annual figure for FY2025 was 339992000.0, up 15.21%.
  • Cash from Operations for Q4 2025 was 130315000.0 at Amneal Pharmaceuticals, up from 118450000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AMRX hit a ceiling of 148128000.0 in Q1 2021 and a floor of 125521000.0 in Q2 2022.
  • Median Cash from Operations over the past 5 years was 83091500.0 (2021), compared with a mean of 64379400.0.
  • Biggest five-year swings in Cash from Operations: crashed 141.7% in 2022 and later soared 683.13% in 2023.
  • Amneal Pharmaceuticals' Cash from Operations stood at 63261000.0 in 2021, then plummeted by 136.82% to 23292000.0 in 2022, then soared by 683.13% to 135823000.0 in 2023, then decreased by 13.06% to 118078000.0 in 2024, then rose by 10.36% to 130315000.0 in 2025.
  • The last three reported values for Cash from Operations were 130315000.0 (Q4 2025), 118450000.0 (Q3 2025), and 83819000.0 (Q2 2025) per Business Quant data.